A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation
Authors:
- 1 June 1998
- journal article
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 81 (1-2) , 19-24
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The in vivo pharmacological profile of a 5‐HT1 receptor agonist, CP‐122, 288, a selective inhibitor of neurogenic inflammationBritish Journal of Pharmacology, 1995
- Neurogenic Model of MigraineCephalalgia, 1995
- Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura materBrain Research, 1993
- Time‐dependent blockade of neurogenic plasma extravasation in dura mater by 5‐HT1B/D agonists and endopeptidase 24.11British Journal of Pharmacology, 1993
- The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and catsAnnals of Neurology, 1993
- Further characterization of the putative 5‐HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura materBritish Journal of Pharmacology, 1991
- The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura materBritish Journal of Pharmacology, 1990
- Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura materEuropean Journal of Pharmacology, 1989
- The Involvement of Trigeminal Substance P Neurons in Cluster Headache. An HypothesisHeadache: The Journal of Head and Face Pain, 1984
- SPECTROPHOTOMETRIC MEASUREMENT OF TRACES OF THE DYE T-1824 BY EXTRACTION WITH CELLOPHANE FROM BOTH BLOOD SERUM AND URINE OF NORMAL DOGSAmerican Journal of Physiology-Legacy Content, 1948